drugset / Trial / NCT05904808

The Heart Failure Diuresis Efficacy Comparison (DEA-HF) Study

NCT05904808

Phase 4 Completed 42 enrolled Rambam Health Care Campus
RandomizedCrossoverOpen-labelTreatment

Summary

To investigate the effectiveness of three (3) IV diuretic regimens to increase natriuresis in volume-overloaded HF patients, allowing for better decongestion and potentially resulting in improved clinical and biochemical parameters outcome.

Timeline

Start
2023-04-19
Primary completion
2023-08-01
Completion
2023-08-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Acetazolamide Small molecule 500 mg Intravenous
Comparator Metolazone Small molecule 5 mg Oral
Comparator Furosemide Other / unclassified 250 mg Intravenous